Načítá se...
Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: results from two prospective cohorts and CALGB 89803 (Alliance) trial
BACKGROUND: Prostaglandin-endoperoxide synthase 2 (PTGS2, cyclooxygenase-2, COX-2)-prostaglandin E(2) (PGE(2)) pathway promotes tumour progression. Considering evidence suggesting increased PGE(2) synthesis by BRAF mutation in tumour cells, we hypothesised that the association of tumour PTGS2 (COX-2...
Uloženo v:
| Vydáno v: | Eur J Cancer |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6436990/ https://ncbi.nlm.nih.gov/pubmed/30826660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2019.01.022 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|